Zhang Luwen, Wang Wei, Liu Xincan, Yan Kuipo, Li Qiang, Li Ming, Li Chunying, Li Yanxin, Chen Lei
The First Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
The First Affiliated Hospital of Henan University of Chinese Medicine, Heart Center/National Regional (Traditional Chinese Medicine) Cardiovascular Diagnosis and Treatment Center, Zhengzhou, Henan, China.
Front Pharmacol. 2025 Apr 2;16:1499060. doi: 10.3389/fphar.2025.1499060. eCollection 2025.
Cardiovascular disease poses a significant risk to human health and remains the leading cause of illness and death globally, with its incidence continuing to rise. The intricate pathophysiological mechanisms of CVDs include inflammation, oxidative stress, autophagy, and myocardial fibrosis. In light of these underlying mechanisms, traditional Chinese medicine (TCM) and its constituents have demonstrated distinct advantages in managing CVDs. By exerting synergistic effects across multiple components and targets, traditional Chinese medicine can modulate the inflammatory response, mitigate oxidative stress, regulate excessive autophagy, and enhance myocardial fibrosis repair. This article reviews the latest advancements in understanding how TCM compounds regulate signaling pathways involved in the treatment of CVDs.
心血管疾病对人类健康构成重大风险,仍然是全球疾病和死亡的主要原因,其发病率持续上升。心血管疾病复杂的病理生理机制包括炎症、氧化应激、自噬和心肌纤维化。鉴于这些潜在机制,传统中药及其成分在管理心血管疾病方面已显示出独特优势。通过在多个成分和靶点上发挥协同作用,传统中药可以调节炎症反应、减轻氧化应激、调节过度的自噬并促进心肌纤维化修复。本文综述了在理解中药化合物如何调节参与心血管疾病治疗的信号通路方面的最新进展。